Home  >  News
Eppen_SpinPro_Apr26
you can get e-magazine links on WhatsApp. Click here
News
  Specialised Therapeutics receives approval from Australia & Singapore for Zepzelca in combo with atezolizumab for advanced small cell lung cancer,   April 21, 2026
  Medprime solves manual pathology bottlenecks with the launch of Cilika AI for faster, scalable diagnostics,   April 21, 2026
  Rusan Pharma achieves global GMP milestone with PMDA Japan approval,   April 21, 2026
  Ampersand Biomedicines presents preclinical data on AMP-220, a gut-targeted IL-22 AND-Body therapeutic, at AAI 2026,   April 21, 2026
  ILS Hospitals partners with MedLern to transform healthcare workforce learning and elevate patient care standards,   April 21, 2026
  AskBio's Viralgen to supply commercial-scale drug product for REGENERATE-PD investigational gene therapy phase II trial for Parkinson’s disease,   April 21, 2026
  AstraZeneca introduces next-gen cardiologists through India Coronary Conquest 2026 with STEMI,   April 21, 2026
  Asahi Kasei initiates phase I trial of AK1940, a novel peptide candidate targeting autoimmune diseases,   April 21, 2026
  CDSCO declares 168 drug samples as NSQs, one as spurious in March,   April 21, 2026
  Orbicular's partner secures tentative US FDA approval for generic version of Ozempic,   April 21, 2026
  CitiusTech appoints Shyam Karunakaran as chief business officer – Payers & Platform Solutions,   April 21, 2026
  Medtronic completes acquisition of medical device company, CathWorks,   April 21, 2026
  Jeena Sikho Lifecare & Sat Kartar Life ink collaboration to build a technology-enabled Ayurveda healthcare ecosystem,   April 21, 2026
  Morepen Labs' Masulkhana facility clears US FDA inspection with Zero adverse observations,   April 21, 2026
  US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility,   April 21, 2026
  Asahi Kasei completes acquisition of Aicuris to advance its global pharmaceutical strategy,   April 21, 2026
  AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint,   April 21, 2026
  China NMPA approves GSK’s Blenrep for treatment of 2L+ relapsed/refractory multiple myeloma,   April 21, 2026
  NPPA seeks market data to fix ceiling price of gentamicin formulation,   April 21, 2026
  Xodus Medical launches US FDA approved Hot Pink Pad, a next-generation patient temperature management and positioning system,   April 20, 2026

 Back
 
Propak_Asia_2026
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram